Aigh Capital Management LLC Context Therapeutics Inc. Transaction History

Aigh Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.61 - $1.42 $90,295 - $210,196	-148,026 Reduced 11.46%	1,143,745 $743,000
Q3 2022 Nov 10, 2022	BUY	$1.11 - $2.08 $111,000 - $208,000	100,000 Added 8.39%	1,291,771 $1.43 Million
Q2 2022 Aug 12, 2022	BUY	$1.29 - $2.66 $1.54 Million - $3.17 Million	1,191,771 New	1,191,771 $1.19 Million
Q1 2022 May 12, 2022	SELL	$1.72 - $2.82 $1.31 Million - $2.15 Million	-762,721 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.66 - $7.45 $2.03 Million - $5.68 Million	762,721 New	762,721 $2.03 Million

56.9M

Ticker CNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,966,100
Market Cap $16.3M
Description
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.